Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

Changes in the Availability of Medications for Opioid Use Disorder in Prisons and Jails in the United States During the COVID-19 Pandemic

During the COVID-19 pandemic, federal agencies relaxed buprenorphine prescribing restrictions including for incarcerated individuals. The impact of COVID-19 on the supply of MOUD in U.S.
Original research | 2022
Policy/Regulatory, Legal system/law enforcement, Substitution/OAT

Characteristics of fatal ‘novel’ synthetic opioid toxicity in Australia

Aims: To determine 1. The characteristics of all recorded cases of fatal drug poisoning involving novel synthetic opioids (NSOs) in Australia; 2. The toxicology of cases; and 3.
Original research | 2022
Overdose, Mortality, About PWUD, Outcomes, Illegal drugs, Drug checking

Efficacy of Heroin-Assisted Treatment in Belgium: A Randomised Controlled Trial

Heroin-assisted treatment (HAT) can improve the condition of heroin addicts still using street heroin after a methadone treatment.
Original research | 2015
Evidence base, Safer supply, About PWUD, Outcomes, Crime, Illegal drugs, Substitution/OAT

Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients’ and prescribers’ experiences with changes in unsupervised dosing

The Ontario COVID-19 OAT Treatment Guidance document was developed to facilitate access to OAT and continuity of care during the pandemic, while supporting physical distancing measures.
Original research | 2021
Evidence base, Policy/Regulatory, Hesitancy of prescribers , Safer supply, Advocacy, About prescribers, About PWUD, Substitution/OAT

Harm reduction must be recognised an essential public health intervention during crises

Commentary | 2021
Policy/Regulatory, Illegal drugs

La pratique émergente de la pharmacothérapie de remplacement

Report | 2021
Harm reduction, Safer supply, About prescribers

Managing a client who is angry or aggressive

If a client becomes aggressive, threatening or potentially violent, it is important for service providers to respond in accordance with the policies and procedures specific to their service.
Webpage | 2016
Harm reduction, About pharmacists, About prescribers, About PWUD, Social services, Illegal drugs, Workplace, SCS/OPS

Opioid Crisis: No Easy Fix to Its Social and Economic Determinants

Commentary | 2017
Policy/Regulatory, Wrap-around services, Equity, Advocacy, About prescribers, Illegal drugs, Substitution/OAT

Opioid Overdose Survivors: Medications for Opioid Use Disorder and Risk of Repeat Overdose in Medicaid Patients

Patients with medically-treated opioid overdose are at high risk for subsequent adverse outcomes, including repeat overdose.
Original research | 2022
Overdose, Harm reduction, About PWUD, Outcomes, Illegal drugs, Substitution/OAT

Opioid related deaths in Norway in 2000-2019

The aim of the study is to present autopsy-based findings of the most prevalent opioids in overdose deaths in Norway from 2000 to 2019
Original research | 2022
Overdose, Mortality, Safer supply, About PWUD, Outcomes, Illegal drugs

Police discretion in encounters with people who use drugs: operationalizing the theory of planned behavior

This study deploys the Theory of Planned Behavior (TPB) to understand what influences police intentions to make discretionary referrals to treatment and harm reduction resources rather than arrest on
Original research | 2021
Social services, Legal system/law enforcement, Illegal drugs, Transitions in care/treatment, Stigma

Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison

Examine during- and post-prison outcomes among people prescribed OAT
Commentary | 2022
Harm reduction, Wrap-around services, About PWUD, Social services, Outcomes, Crime, Legal system/law enforcement, Substitution/OAT

Toxicology and prescribed medication histories among people experiencing fatal illicit drug overdose in British Columbia, Canada

Our objective was to assess prescription history in the context of postmortem toxicology among people who had a fatal illicit drug overdose in BC.
Original research | 2020
Overdose, Mortality, Evidence base, Safer supply, Outcomes, Illegal drugs, Stimulants

Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings

This study assessed the safety of subcutaneous slow-release depot buprenorphine in custody.
Original research | 2022
Outcomes, Legal system/law enforcement, Substitution/OAT, Diversion

Understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study

The aim of this work was to understand (1) the perspectives of family physicians (FPs) as it relates to opioid prescribing, and (2) the perceived barriers and enablers to guideline-adherent opioid pre
Original research | 2019
Clinical guidance, Policy/Regulatory, Hesitancy of prescribers , Safer supply, About prescribers, Barriers and enablers, Chronic pain

A Treatment Algorithm for Attention Deficit Hyperactivity Disorder in Cocaine-Dependent Adults: A One-Year Private Practice Study with Long-Acting Stimulants, Fluoxetine, and Bupropion

We report evidence that study subjects probably medicated their ADHD symptoms with cocaine and describe a 1‐year treatment algorithm featuring long‐acting stimulants that was effective in the manageme
Original research | 1999
About prescribers, Outcomes, Illegal drugs, Stimulants

Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015–2019

Cannabis legalization in many jurisdictions worldwide has raised concerns that such legislation might increase the burden of transient and persistent psychotic illnesses in society.
Original research | 2022
Policy/Regulatory, Mental health

Crystal Meth, Opiates, Overdose and Housing in Kingston, Ontario: 2021 Rapid Assessment and Reponse

The people who frequent the Integrated Care Hub (ICH) – its stakeholders – know best what they are experiencing and what they need.

Report | 2021
Overdose, Evidence base, Harm reduction, Policy/Regulatory, Wrap-around services, Safer supply, Decriminalization/legalization, Equity, About PWUD, Social services, Barriers and enablers, Poverty, Housing, Crime, Legal system/law enforcement, Illegal drugs, Chronic pain, Indigenous, Small/medium cities, Stimulants, Sex/Gender , Stigma, Mental health

Drug Overdose Mortality by Race/Ethnicity across US-Born and Immigrant Populations

Examined racial/ethnic differences in US drug overdose mortality among US-born and foreign-born men and women.
Original research | 2022
Overdose, Mortality, Equity, Illegal drugs

Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness

During a COVID-19 outbreak in the congregate shelter system in Halifax, Nova Scotia, Canada, a multidisciplinary health care team provided an emergency “safe supply” of pharmaceutical-grade medicat

Original research | 2022
Harm reduction, Policy/Regulatory, Safer supply, About PWUD, Social services, Outcomes, Poverty, Housing, Small/medium cities

Affiner votre recherche

Mots clés
Format
Région